New York 2023-2024 Regular Session

New York Senate Bill S01187

Introduced
1/10/23  
Refer
1/10/23  

Caption

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

Companion Bills

NY A01641

Same As Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

Previously Filed As

NY A01641

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY S01282

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY A01439

Requires health insurance policies to offer full coverage for annual testing for ovarian cancer; requires certain health care providers offer annual testing for ovarian cancer.

NY SB518

Health Insurance - Screening for Ovarian Cancer - Required Coverage and Prohibited Cost Sharing

NY HB633

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

NY HB0633

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

NY SB551

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage and Prohibited Cost Sharing

NY A06087

Requires health insurance policies to fully cover multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.

NY S327

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

NY A06509

Relates to ovarian cancer research; requires biennial reporting on recommendations from the health research and science board on the types of data that would be useful for ovarian cancer researchers.

Similar Bills

No similar bills found.